As sequencing costs come down ... paediatric cancers driven by variants that are not included in traditional gene-panel tests 2. By using whole genome and transcriptome sequencing, researchers ...

Epigenome Sequencing, Tumor Panel, and other huge sequencing projects. Driven by MGI’s unique DNBSEQ TM Technology, DNBSEQ-T7* is making use of completely upgraded fluidics, biochemical ...

Oxford Gene Technology has announced the launch of its newly updated NGS SureSeq™ CLL + CNV V3 Panel. This new panel was ...

Epigenome Sequencing, Tumor Panel, and other large sequencing projects. Driven by MGI’s unique DNBSEQ TM Technology, DNBSEQ-T7, fully upgrading fluidics, biochemical, and optical systems makes ...

In patients with familial PAH, SMAD5 appears to be a novel gene that warrants consideration for genetic testing, according to ...

[8–12] A less known hybridization-based enrichment strategy uses filters, marked with amplicons, to capture targeted DNA libraries. [37] To achieve this, the selected target regions must be PCR ...

With current NGS platforms, the boundaries of variant detection and gene content for genetic disease panels has been vastly expanded leading to increases in detection rates. However these platforms ...

The guidance highlighted the need to define mechanisms of antimicrobial resistance (AMR) to guide and tailor therapy. In this presentation, we will describe the newly FDA-cleared Acuitas AMR Gene ...

As next-generation sequencing becomes more accessible, scientists gain unprecedented resolution to explore the underpinnings of health and disease. The information they have obtained has ...

1 While patients may receive targeted multi-gene panel testing ... address these challenges by increasing access to whole exome sequencing for pediatric epilepsy patients. In addition to helping ...